Current Neuro-Oncology

Volume 27 Number 32
20 November 2025

Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 32, 20 November

Zhang G, Zhou H, Han W, Lou L, Xue X.
Prognostic modeling for diffuse midline glioma: development and validation of a risk stratification nomogram using SEER and institutional cohorts.
Front Oncol. 2025 Oct 27;15:1644388. doi: 10.3389/fonc.2025.1644388. PMID: 41220938. Observational study. ˍ

Huang B, Liu T, Li H, Li X, Lu G, Li J.
Epidemiological characteristics and prognostic factors of high-grade brainstem glioma for all ages and the establishment of a nomogram.
Transl Cancer Res. 2025 Oct 29;14(10):7186-7198. doi: 10.21037/tcr-2025-1030. PMID: 41234848. Observational study. ˍ

Padilla O, Tazhibi M, McQuillan N, Buss EJ, Sisti MB, Bruce JN, McKhann GM, Cheng SK, Wang TJC.
Sex-Based Differences in Outcomes for Glioblastoma Patients Treated with Hypofractionated Chemoradiotherapy.
Cancers (Basel). 2025 Oct 30;17(21):3486. doi: 10.3390/cancers17213486. PMID: 41228279. Observational study. ˍ

Wang J, Niu X, Chang T, Quan Y, Mwibwe LM, Liu Y, Wang X, Yang Y, Mao Q.
The impact of maximized resection and standardized systemic therapy on overall survival in adult patients with thalamic gliomas.
Front Oncol. 2025 Oct 30;15:1681695. doi: 10.3389/fonc.2025.1681695. PMID: 41244892. Observational study. ˍ

Yamada K, Matsuda R, Sasaki R, Maeoka R, Nakazawa T, Morimoto T, Morisaki Y, Yokoyama S, Kotsugi M, Takeshima Y, Yamada S, Nishimura F, Park YS, Nakagawa I.
Postoperative Seizures Can Predict Overall Survival of Patients With Newly Diagnosed Supratentorial Isocitrate Dehydrogenase-Wild Glioblastoma Treated With Radiotherapy Plus Concomitant and Adjuvant Temozolomide.
Brain Tumor Res Treat. 2025 Oct 31;13(4):140-146. doi: 10.14791/btrt.2025.0022. PMID: 41218815. Observational study. ˍ

Wu CC, Szalontay L, Pouliopoulos AN, Bae S, Berg X, Wei HJ, Webster Carrion A, Kokossis D, Sethi C, Fino J, Shatravka H, Lipina J, Ji R, Liu K, Yousefian O, Gallitto M, Yoh N, Englander Z, McQuillan N, Tazhibi M, De Los Santos G, Canoll P, Jin Z, Garvin J, Gartrell RD, Pavisic J, Maddocks A, Lignelli A, Feldstein N, Konofagou EE, Zacharoulis S.
Blood-brain barrier opening with neuronavigation-guided focused ultrasound in pediatric patients with diffuse midline glioma.
Sci Transl Med. 2025 Nov 12;17(824):eadq6645. doi: 10.1126/scitranslmed.adq6645. PMID: 41223245. Interventional study. ˍ

Lenga P, Scherer M, Dao Trong P, Krieg SM, Suchorska B.
Sex-specific disparities in postoperative adverse events following intracranial tumor surgery: insights from a tertiary neurosurgical center.
Acta Neurochir (Wien). 2025 Nov 13;167(1):292. doi: 10.1007/s00701-025-06708-z. PMID: 41231356. Observational study. ˍ

Truusalu JP, Oselin K, Lass J, Buck KK, Sietsema W, Soeorg H, Toome K, Kaarna K, Teesalu T, Kõrgvee LT.
LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiforme.
BMJ Open. 2025 Nov 13;15(11):e106094. doi: 10.1136/bmjopen-2025-106094. PMID: 41248393. Interventional study protocol. ˍ

Zeyen T, Krause I, Decker A, Kroh F, Regnery S, Weller J, Schaefer N, Zidan M, Potthoff AL, Schneider M, Friker LL, Keupp J, Katemann C, Layer JP, Schaub C, Gkika E, Vatter H, Pietsch T, Radbruch A, Herrlinger U, Paech D.
Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastoma.
Neuro Oncol. 2025 Nov 13:noaf261. doi: 10.1093/neuonc/noaf261. PMID: 41233976. Observational study. ˍ

Lohela J, Lehtiö K, Inget K, Karhula SS, Piironen S, Suutari A, Knuutinen A, Jänkälä M, Lammentausta E, Bode MK, Nikkinen J, Salokorpi N, Keinänen T.
Improved brain tumor diagnostics and follow-up with novel magnetic resonance imaging methods: A single center study protocol.
PLoS One. 2025 Nov 14;20(11):e0336387. doi: 10.1371/journal.pone.0336387. PMID: 41237103. Interventional study protocol. ˍ

Silver DJ, Poplawski GHD, Lathia JD.
Opposing Functions of White Matter in Glioblastoma.
Neuro Oncol. 2025 Nov 14:noaf266. doi: 10.1093/neuonc/noaf266. PMID: 41234043. Editorial. ˍ

Zhang W, Lin L, Li Y, Wang Y, Shen H, Guan Y.
Glioblastoma with cerebrospinal fluid dissemination and MYC gene amplification: A transitional or atypical glioblastoma with primitive neuronal components.
Medicine (Baltimore). 2025 Nov 14;104(46):e44072. doi: 10.1097/MD.0000000000044072. PMID: 41239669. Case report. ˍ

Al Qudah H, D Hamilton J, A Gubbiotti M, Msherghi A, Salim HA, Alizada S, Liu HL, Kumar VA, Wintermark M, Eldaya RW.
Imaging features of high-grade astrocytoma with piloid features: A single center case series.
Neuroradiol J. 2025 Nov 15:19714009251395689. doi: 10.1177/19714009251395689. PMID: 41239912. Observational study. ˍ

Faison SL, Batonga J, Arumugham T, Bartkus A, Morrison ME, Mullin MJ, Tippin T, Naderer O.
A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Dordaviprone.
J Clin Pharmacol. 2025 Nov 15. doi: 10.1002/jcph.70129. PMID: 41239907. Interventional study˰ ˍ

Mata-Mbemba D, Trasolini A, Maianski I, McFadden K, Crowell C, Moineddin R, Sargent M, Cheng S, Perreault S, Erker C.
Molecular subtype prediction model for pediatric low-grade gliomas using conventional neuroradiology reporting.
Childs Nerv Syst. 2025 Nov 15;41(1):355. doi: 10.1007/s00381-025-07024-8. PMID: 41240147. Observational study˰ ˍ

Wach J, Weber F, Wende T, Vychopen M, Barrantes-Freer A, Pfahl A, Köhler H, Güresir E.
GLIMMER: an interim subgroup analysis from an ongoing prospective study evaluating hyperspectral imaging for MGMT promoter methylation in gliomas.
J Neurooncol. 2025 Nov 17;176(1):86. doi: 10.1007/s11060-025-05340-2. PMID: 41247617. Interventional study. ˍ

Weiner S, Warmuth-Metz M, Kandels D, Timmermann B, Kortmann RD, Dietzsch S, Pietsch T, Bison B, Pham M, Gnekow AK, Quenzer A.
Decreased T2-signal intensities indicate positive response to front-line radiotherapy in pediatric low-grade gliomas.
Radiol Med. 2025 Nov 17. doi: 10.1007/s11547-025-02118-4. PMID: 41247651. Observational study. ˍ

Yang Z, Tunje RC, Xia J, Sun C.
*Designing a web-based platform for dynamic estimation of individualized conditional survival in grade 3 gliomas.
Discov Oncol. 2025 Nov 17;16(1):2111. doi: 10.1007/s12672-025-03885-2. PMID: 41249681. Observational study. ˍ

Raghu A, Killar S, Cohen AL.
Effects of temozolomide dosing on outcome in glioblastoma.
J Neurooncol. 2025 Nov 19;176(1):89. doi: 10.1007/s11060-025-05324-2. PMID: 41258619. Observational study. ˍ